RT Journal Article
SR Electronic
T1 Prevalence of anxiety, depression, and stress among teachers during the COVID-19 pandemic: Systematic review
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.05.01.21256442
DO 10.1101/2021.05.01.21256442
A1 Silva, David Franciole Oliveira
A1 Cobucci, Ricardo Ney Oliveira
A1 Lima, Severina Carla Vieira Cunha
A1 de Andrade, Fábia Barbosa
YR 2021
UL http://medrxiv.org/content/early/2021/05/05/2021.05.01.21256442.abstract
AB Objective Identifying the prevalence of anxiety, depression, and stress among teachers during the COVID-19 pandemic.Methods Systematic review of original studies published in any language. Protocol published in PROSPERO under number CRD42021240543. The search was carried out in the Web of Science, PsycINFO, Pubmed, Embase, LILACS, and SciELO databases, using the descriptors: anxiety, depression, stress, teacher, faculty, COVID-19, and their synonyms. Narrative synthesis was carried out in line with the synthesis without meta-analysis (SWiM) in systematic reviews.Results Of the 1,372 records identified, six studies, all cross-sectional, were included in the review. The studies were carried out in China, Brazil, the United States of America, India, and Spain. Five studies included more women than men. The participants were aged from 24 to 60 years. Three studies included only school teachers, two included schools and universities teachers, and one only university teachers. Of the five studies, all dealt with remote activities and only one included teachers who returned to face-to-face classes one to two weeks ago. The prevalence of anxiety ranged from 10% to 49.4%, and depression from 15.9% to 28.9%, being considerably higher in studies with teachers who worked in schools. The prevalence of stress ranged from 12.6% to 50.6%.Conclusions The prevalence of anxiety, depression, and stress was high among teachers during the pandemic, with great variation between studies. Anxiety and stress were more prevalent in the Spanish study. The results show the need for measures for the care of teachers’ mental health, especially when returning to face-to-face classes.What is already known about this subject?➢ With remote classes during the COVID-19 pandemic, there were changes in the professional practice of teachers.➢ Sudden changes in professional practice can result in increased levels of anxiety, depression, and stress.➢ Returning to face-to-face classes can also result in increased levels of anxiety, depression, and stress.What are the new findings?➢ The prevalence of anxiety ranged from 10% to 49.4%, with higher rates recorded in female teachers, with comorbidities and working in schools.➢ The prevalence of depression ranged from 15.9% to 28.9%, with higher rates identified in school teachers.➢ The prevalence of stress varied from 12.6% to 50.6%, with higher rates observed among female teachers and those with chronic diseases.➢ The only study that performed data collection during the return to face-to-face classes registered a higher prevalence of anxiety and stress than the other studies, in which the research was carried out during remote classes.How might this impact policy or clinical practice in the foreseeable future?➢ Better training of teachers to handle the remote education model can contribute to preventing work overload and mental problems. Further, pedagogical and psychological support, especially for those who work in schools, can also prove effective.➢ The return to face-to-face classes can increase stress and anxiety. Ensuring bio-safety protocols for safe return to face-to-face activities, can contribute to mitigating anxiety and stress about the risk of contracting the disease.➢ There is insufficient evidence to determine a cause and effect relationship of the COVID-19 pandemic with anxiety, depression, and stress among teachers. Prospective cohort studies with control of confounding factors are necessary to infer that the pandemic has increased mental health problems in these professionals.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) Finance Code 001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NA - systematic review.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData available on reasonable request.